Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity
- 31 May 1991
- Vol. 9 (5) , 334-339
- https://doi.org/10.1016/0264-410x(91)90060-j
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Homotypic and Heterotypic Epitope-Specific Antibody Responses in Adult and Infant Rotavirus Vaccinees: Implications for Vaccine DevelopmentThe Journal of Infectious Diseases, 1990
- Rhesus Rotavirus Candidate VaccineAmerican Journal of Diseases of Children, 1990
- Field trial of rhesus rotavirus vaccine in infantsThe Pediatric Infectious Disease Journal, 1988
- Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006The Pediatric Infectious Disease Journal, 1988
- Perspective on the development and deployment of rotavirus vaccinesThe Pediatric Infectious Disease Journal, 1987
- PROTECTION AGAINST SEVERE ROTAVIRUS DIARRHOEA BY RHESUS ROTAVIRUS VACCINE IN VENEZUELAN INFANTSThe Lancet, 1987
- PROTECTIVE EFFECT OF NATURALLY ACQUIRED HOMOTYPIC AND HETEROTYPIC ROTAVIRUS ANTIBODIESPublished by Elsevier ,1986
- Evaluation of Rhesus Rotavirus Vaccine (MMU 18006) in Infants and Young ChildrenThe Journal of Infectious Diseases, 1986
- Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infantsThe Pediatric Infectious Disease Journal, 1986
- Serotypic Similarity and Diversity of Rotaviruses of Mammalian and Avian Origin as Studied by Plaque-Reduction NeutralizationThe Journal of Infectious Diseases, 1984